519 (Carbidopa and Levodopa 25 mg / 250 mg)
Pill imprint 519 has been identified as Carbidopa and levodopa 25 mg / 250 mg.
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 519 (Carbidopa and Levodopa 25 mg / 250 mg)
- 25 mg / 250 mg
- 15.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Sun Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
FD&C Blue No. 2
More about carbidopa/levodopa
- Carbidopa/levodopa orally disintegrating tablets
- Carbidopa/levodopa sustained-release tablets
- Carbidopa and levodopa
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...